ViPOR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ViPOR, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma [Phase 2]